CGP 52608
Chemical compound
From Wikipedia, the free encyclopedia
CGP 52608 is a selective ligand of the RAR-related orphan receptor alpha.[1] It has been used as a biochemical tool to investigate nuclear and membrane signaling of melatonin.[1] CGP 52608 has also been reported to possess antiarthritic activity.[2] The pharmaceutical company Novartis brought it to clinical trials for rheumatoid arthritis, but development was discontinued in 2006.[3]
| Names | |
|---|---|
| IUPAC name
3-Methyl-1-[(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C8H12N4OS2 | |
| Molar mass | 244.33 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
CGP 52608 contains a thiazolinidinedione group.[4]
